BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 17131332)

  • 1. Elucidation of a protein signature discriminating six common types of adenocarcinoma.
    Bloom GC; Eschrich S; Zhou JX; Coppola D; Yeatman TJ
    Int J Cancer; 2007 Feb; 120(4):769-75. PubMed ID: 17131332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles.
    Giordano TJ; Shedden KA; Schwartz DR; Kuick R; Taylor JM; Lee N; Misek DE; Greenson JK; Kardia SL; Beer DG; Rennert G; Cho KR; Gruber SB; Fearon ER; Hanash S
    Am J Pathol; 2001 Oct; 159(4):1231-8. PubMed ID: 11583950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors.
    Chen G; Gharib TG; Huang CC; Thomas DG; Shedden KA; Taylor JM; Kardia SL; Misek DE; Giordano TJ; Iannettoni MD; Orringer MB; Hanash SM; Beer DG
    Clin Cancer Res; 2002 Jul; 8(7):2298-305. PubMed ID: 12114434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics-based identification of a group of apoptosis-related proteins and biomarkers in gastric cancer.
    Bai Z; Ye Y; Liang B; Xu F; Zhang H; Zhang Y; Peng J; Shen D; Cui Z; Zhang Z; Wang S
    Int J Oncol; 2011 Feb; 38(2):375-83. PubMed ID: 21165559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma.
    Liu YF; Xiao ZQ; Li MX; Li MY; Zhang PF; Li C; Li F; Chen YH; Yi H; Yao HX; Chen ZC
    J Pathol; 2009 Jan; 217(1):54-64. PubMed ID: 18798225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative proteomics and global genome-wide expression data implicate role of ARMC8 in lung cancer.
    Amin A; Bukhari S; Mokhdomi TA; Anjum N; Wafai AH; Wani Z; Manzoor S; Koul AM; Amin B; Ain QU; Qazi H; Tyub S; Lone GN; Qadri RA
    Asian Pac J Cancer Prev; 2015; 16(9):3691-6. PubMed ID: 25987023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic biomarker predicts therapeutical effects of oxaliplatin combining with fluoropyrimidine in metastatic gastric cancer patients by the SELDI-proteinchip platform.
    Yu Z; Yu JK; Fang XF; Yuan Y; Shen H
    Hepatogastroenterology; 2013 Oct; 60(127):1800-4. PubMed ID: 24624447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SELDI protein profiling of dunning R-3327 derived cell lines: identification of molecular markers of prostate cancer progression.
    Malik G; Rojahn E; Ward MD; Gretzer MB; Partin AW; Semmes OJ; Veltri RW
    Prostate; 2007 Oct; 67(14):1565-75. PubMed ID: 17705230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor classification of six common cancer types based on proteomic profiling by MALDI imaging.
    Meding S; Nitsche U; Balluff B; Elsner M; Rauser S; Schöne C; Nipp M; Maak M; Feith M; Ebert MP; Friess H; Langer R; Höfler H; Zitzelsberger H; Rosenberg R; Walch A
    J Proteome Res; 2012 Mar; 11(3):1996-2003. PubMed ID: 22224404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear matrix proteins in human colon cancer.
    Keesee SK; Meneghini MD; Szaro RP; Wu YJ
    Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1913-6. PubMed ID: 8127905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of chemotherapy resistance in breast cancer identified by proteomics: current status.
    Hodgkinson VC; Eagle GL; Drew PJ; Lind MJ; Cawkwell L
    Cancer Lett; 2010 Aug; 294(1):13-24. PubMed ID: 20176436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of fascin and CK14 in different histological types of cancer and its differential diagnostic significance].
    Xue LY; Zou SM; Zheng S; Xie YQ; Wen P; Liu XY; Lin DM; Lü N
    Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):838-44. PubMed ID: 21223690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative proteomics of primary breast carcinomas and lymph node metastases outlining markers of tumor invasion.
    Milioli HH; Santos Sousa K; Kaviski R; Dos Santos Oliveira NC; De Andrade Urban C; De Lima RS; Cavalli IJ; De Souza Fonseca Ribeiro EM
    Cancer Genomics Proteomics; 2015; 12(2):89-101. PubMed ID: 25770193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach.
    Li R; Wang H; Bekele BN; Yin Z; Caraway NP; Katz RL; Stass SA; Jiang F
    Oncogene; 2006 Apr; 25(18):2628-35. PubMed ID: 16369491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
    Bishop JA; Sharma R; Illei PB
    Hum Pathol; 2010 Jan; 41(1):20-5. PubMed ID: 19740516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
    Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
    Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic study of malignant pleural mesothelioma by laser microdissection and two-dimensional difference gel electrophoresis identified cathepsin D as a novel candidate for a differential diagnosis biomarker.
    Hosako M; Muto T; Nakamura Y; Tsuta K; Tochigi N; Tsuda H; Asamura H; Tomonaga T; Kawai A; Kondo T
    J Proteomics; 2012 Jan; 75(3):833-44. PubMed ID: 22051404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen biomarkers for early diagnosis of lung adenocarcinoma].
    Tian YX; Yang SY; Nan YD; Zhang W; Yu JK; Zheng S
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):157-61. PubMed ID: 19292069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of cytokeratin 7 and 20 in ovarian metastatic carcinomas].
    Dai L; Song Q; Li L; Zhong D; Hui Y
    Zhonghua Bing Li Xue Za Zhi; 2001 Apr; 30(2):114-7. PubMed ID: 11866966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.